BlueRock’s Phase I study with bemdaneprocel in patients with Parkinson’s disease meets primary endpoint
Berlin, Germany, Cambridge, MA, USA, August 28, 2023 – Bayer AG and BlueRock Therapeutics LP, a clinical stage cell therapy ...
Read moreDetails
Tag: BlueRock’s
The Earth News is an independent English-language daily published Website from all around the World News
